Daya Intiguna Yasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Daya Intiguna Yasa Tbk. trades at Rp1,005 (market cap 24.69T, 294.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Daya Intiguna Yasa Tbk. is far larger — about 147.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Daya Intiguna Yasa Tbk. is more actively traded (294.2K versus 96.7K). Which is the better fit depends on your goals.
| MDIY | OBAT | |
|---|---|---|
Market Cap | 24.69T | 167.37B |
Volume | 294.2K | 96.7K |
Lot | 2.94K | 967 |
Turnover | 291.47M | 23.82M |
Average Price | 990.73 | 246.34 |
Value | 291.47M | 23.82M |
Indicative Equilibrium Price | 1,005 | 248 |
Indicative Equilibrium Volume | 96 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Daya Intiguna Yasa Tbk (the Company) was established based on Notarial Deed No. 7 dated 27 March 2017 of notary Drs. Bambang T Anggono Budi, S.H., M.Kn. The Company commenced its commercial operations on March 2017. The Company direct parent entity is Azara Alpina Sdn Bhd, a company incorporated and domiciled in Malaysia. The Company ultimate parent and individual entity is Mr DIY International Holding Ltd and Mr. Tan Yu Yeh, a company and individual that incorporated and domiciled in Malaysia.
Read more on MDIY →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →